Suchergebnisse - "1568-0096" OR "1873-5576"

PubPharm (41)

1

Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies

enthalten in: Current cancer drug targets | 2024

von Mohite, R. | Doshi, G.

2

Saikosaponin B4 Suppression Cancer Progression by Inhibiting SW480 and SW620 Cells Proliferation via the PI3K/AKT/mTOR Pathway in Colon Cancer

enthalten in: Current cancer drug targets | 2022

von Zhang, Y. | Lin, L. | Wang, Y. | +4

3

Cucurbitacin D Inhibits the Proliferation of HepG2 Cells and Induces Apoptosis by Modulating JAK/STAT3, PI3K/Akt/mTOR and MAPK Signaling Pathways

enthalten in: Current cancer drug targets | 2022

von Mehdi Üremiş, M. | Üremiş, N. | Tosun, E. | +4

4

Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway

enthalten in: Current cancer drug targets | 2022

von Yiyan, S. | Yang, S. | Li, D. | +1

5

Inhibition of PI3K/mTOR Pathways with GDC-0980 in Pediatric Leukemia : Impact on Abnormal FLT-3 Activity and Cooperation with Intracellular Signaling Targets

enthalten in: Current cancer drug targets | 2019

von Al-Ghabkari, A. | Perinpanayagam, M. | Narendran, A.

6

Clinical Evidence on the Magnitude of Change in Growth Pathway Activity in Relation to Tamoxifen Resistance is Required

enthalten in: Current cancer drug targets | 2018

von Mansouri, S. | Farahmand, L. | Teymourzadeh, A. | +1

7

The PI3K Pathway at the Crossroads of Cancer and the Immune System : Strategies for Next Generation Immunotherapy Combinations

enthalten in: Current cancer drug targets | 2018

von Collins, D. | Chenard-Poirier, M. | Lopez, J.

8

Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma

enthalten in: Current cancer drug targets | 2017

von Wang, G. | Fu, X. | Wang, J. | +2

9

Polyphyllin II Restores Sensitization of the Resistance of PC-9/ZD Cells to Gefitinib by a Negative Regulation of the PI3K/Akt/mTOR Signaling Pathway

enthalten in: Current cancer drug targets | 2017

von Zheng, R. | Jiang, H. | Li, J. | +2

10

The Novel VEGF121-VEGF165 Fusion Attenuates Angiogenesis and Drug Resistance via Targeting VEGFR2-HIF-1α-VEGF165/Lon Signaling Through PI3K-AKT-mTOR Pathway

enthalten in: Current cancer drug targets | 2016

von Tsai, J. | Lee, Y. | Pan, C. | +1

1
2
3
4
5
Nächster »
[5]